by Carly Helfand |
“We had no idea what we were getting into,” said Perry Davidson, CEO of inhaler maker Syqe, which will present next week at the MIXiii-BIOMED conference in Tel Aviv. Davidson and his colleagues set about creating an inhaler for pharma-grade cannabis back in 2011 with “no personal background in this field.”
Source: https://www.fiercebiotech.com/medtech/here-s-some-advice-for-medtech-startups-don-t-do-your-homework-ceos-say